Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bing Xia
Observed name:
Xia, Bing
Institutions:
Zhejiang Chinese Medical University,
Westlake University,
Zhejiang Cancer Hospital,
Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine,
Hangzhou Cancer Hospital
Observed institutions:
Zhejiang Chinese Medical University,
Westlake University,
Zhejiang Cancer Hospital,
Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine,
Hangzhou Cancer Hospital,
Zhejiang University
show all 6
ORCID:
0000-0002-9178-5493
Observed ORCID:
0000-0002-9178-5493
OpenAlex ID:
A5038820059
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial
2021
·
Huiyan Luo
, Jin Lu
, et al.
·
JAMA
·
874
PDF
Real-World Treatment Patterns and Clinical Outcomes in EGFR-Mutant Unresectable Locally Advanced Lung Adenocarcinoma: A Multi-Center Cohort Study
2020
·
Nan Bi
, Kunpeng Xu
, et al.
·
Journal of the National Cancer Center
·
20
Advances in CT features and radiomics of checkpoint inhibitor-related pneumonitis: A short review
2023
·
Jie Huang
, Xueqin Chen
, et al.
·
Frontiers in Immunology
·
14
PDF
Optimized patient-derived lung cancer organoids recapitulating the immune landscape for precision therapy evaluation
2026
·
Huayang Xing
, Rui Liu
, et al.
·
Cellular Oncology
·
8
PDF
Patient-derived malignant effusion organoids guide tailored therapy and dissect third-generation EGFR-tyrosine kinase inhibitor resistance mechanisms in lung cancer
2026
·
Yidan Chen
, Huayang Xing
, et al.
·
Cancer Letters
·
5
Untitled
2024
·
Zhibing Wu
, Shigang Ding
, et al.
·
Journal of Organoid and Bioscience
·
1
PDF
Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer
2026
·
Jiafeng Liang
, Lucheng Zhu
, et al.
·
Discover Oncology
Correction to: Bevacizumab reduces PD-L1 Not PD-1 inhibitor-associated pneumonitis in non-small cell lung cancer patients
2026
·
Lingling Wang
, Yasi Xu
, et al.
·
Cancer Immunology Immunotherapy
PDF
Integrated multi-omics profiling of pulmonary signet ring cell adenocarcinoma to reveal diagnostic markers, immune subtypes, and therapeutic vulnerabilities.
2026
·
Xiaochen Zhang
, Shirong Zhang
, et al.
·
Journal of Clinical Oncology
PDF
Polyclonal-Monoclonal Transition in Lung Squamous Cell Carcinoma Evolution
2026
·
Taoyu Zhu
, Yaping Xu
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Development of a machine learning-based model to predict prognosis of resected invasive pulmonary adenocarcinoma
2025
·
Jie Huang
, Jiannan Qian
, et al.
·
Journal of Thoracic Disease
Safety of osimertinib in Chinese patients with non-small cell lung cancer: a multi-center, prospective, observational study
2025
·
Hua Zhong
, Shunjun Jiang
, et al.
·
Future Oncology
Expert Consensus on Patient Derived Tumor Organoid Culture and Drug Sensitivity Testing
2024
·
Zhibing Wu
, Shigang Ding
, et al.
·
Journal of Organoid and Bioscience
PDF
Show more works
View as search
Works count:
14
Citation count:
920
H-index:
5
I10-index:
3
Year
Topic
Type